CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 213,400	$ 243,800
Cost of sales	145,200	164,100
Gross margin	68,200	79,700
Selling, general and administrative expenses	47,500	60,100
Research and development expenses	8,900	9,600
Restructuring and impairment charges	100	10,500
Other operating (income) expense, net	0	(200)
Operating income (loss)	11,700	(300)
Equity income in unconsolidated joint ventures	300	100
Other income (expense), net	400	100
Interest expense, net	(800)	(3,500)
Income (loss) before income taxes	11,600	(3,600)
Income tax expense (benefit)	3,800	(100)
Net income (loss)	$ 7,800	$ (3,500)
Basic earnings per share (in dollars per share)	$ 0.42	$ (0.19)
Diluted earnings per share (in dollars per share)	$ 0.42	$ (0.19)
Shares used in computing:
Basic earnings per share (in shares)	18.6	18.6
Diluted earnings per share (in shares)	18.7	18.6